Accelerate Biotech R&D with Benchling Validated Cloud

KB at your finger tips

This is one stop global knowledge base where you can learn about all the products, solutions and support features.

Products-Benchling

Accelerate Biotech R&D with Benchling Validated Cloud

Enhancing Compliance and Efficiency

Benchling Validated Cloud offers a comprehensive solution designed to accelerate time-to-market for biotech companies while ensuring compliance with stringent regulatory requirements. By providing a unified platform with compliance controls, Benchling empowers users to maintain GxP readiness and streamline data packages for regulatory filings. This solution not only expedites tech transfers but also enhances data integrity, enabling organizations to operate within the constraints of regulatory frameworks.

Ensuring User Compliance and GxP Readiness

With Benchling Validated Cloud, organizations can enforce user compliance through application controls and e-signature functionalities compliant with 21 CFR Part 11 and Annex 11. The platform allows users to verify the correct execution of GxP workflows, review audit trails with visible timestamps, and track system changes with controlled user access. These features ensure that organizations adhere to regulatory standards and are always audit-ready, minimizing compliance risks.

Key Capabilities of Benchling Validated Cloud

Benchling Validated Cloud offers a controlled, validated tenant for managing GxP workflows and reducing compliance risks. The platform provides compliance functionality to meet the latest regulatory, security, and quality requirements, along with validation and audit support to facilitate quick validation processes. Additionally, Benchling enables users to capture experimental data in structured formats, maintain a harmonized data model for consistency, and streamline collaboration and workflow management across teams.

Customer Testimonials and Industry Recognition

Leading biotech organizations, including Fortune 500 companies, startups, and academic institutions, trust Benchling for its validated cloud solution. With over 200,000 scientists leveraging Benchling's platform, the company has gained recognition for powering breakthroughs in the biotechnology industry. Testimonials from users like Nermin Avdispahic, Quality Control Manager at New England Biolabs, highlight the platform's ability to meet regulatory compliance requirements and enhance structured data management for a competitive edge.

Learn More and Explore Benchling Validated Cloud

Organizations can access detailed resources such as data sheets, webinars, and white papers to learn more about Benchling Validated Cloud. By requesting a demo, businesses can experience firsthand how Benchling's platform accelerates biotech R&D, improves compliance, and drives innovation. Trusted by over 1,200 biotechnology companies, Benchling continues to enable groundbreaking discoveries in the industry through its validated cloud solution.

Stay Ahead in Today’s Competitive Market!
Unlock your company’s full potential with a Virtual Delivery Center (VDC). Gain specialized expertise, drive seamless operations, and scale effortlessly for long-term success.

Book A Meeting To Setup A VDC

Accelerate Antibody Discovery with Benchling's AI-Powered Solutions

Centralized and Unified R&D Data

Benchling offers a trusted and open cloud platform to centralize and unify all research and development (R&D) data. By leveraging Benchling, organizations can streamline their data management processes, ensuring that all data is easily accessible and organized in a single platform. This centralized approach enhances collaboration and communication between different workstreams, allowing for seamless sharing of information and fostering a more cohesive research environment.

Read article

Accelerate Your Cell Therapy Breakthrough with Benchling's R&D Solutions

The Importance of Modern Digital R&D in Cell Therapy

Cell therapies have revolutionized the medical field by harnessing the body's immune system for treating diseases like never before. Innovations in Tumor-Infiltrating Lymphocyte Therapy, Engineered T Cell Receptor Therapy, CAR T Cell Therapy, and NK Cell Therapy are showcasing the potential of these therapies. However, successful cell therapy R&D demands a robust digital foundation. It is crucial to design cutting-edge constructs, conduct complex characterizations, and track production processes comprehensively. Maintaining full traceability across sequences, cell lines, patient donors, and engineering processes is vital for gaining critical insights throughout the R&D journey.

Read article

Empowering Biopharma Innovation: Benchling's Comprehensive Content Library

State of Tech in Biopharma Report

Dive into the 2024 State of Tech in Biopharma Report, based on insights from 300 biopharma experts. Gain a deep understanding of the investments, readiness, and expected outcomes from AI in an industry experiencing rapid transformation. This white paper offers valuable insights for organizations looking to stay ahead in the biopharma sector.

Read article

Empowering Industrial Biotechnology Research and Development with Benchling

Accelerate Innovation in the New Bioeconomy

In the current era of sustainable alternatives, industrial biotechnology plays a pivotal role in various sectors like agriculture, biofuels, chemicals, consumer goods, food and beverage, and materials. With a focus on boosting innovation, research and development teams are leveraging cutting-edge science to design novel strains, revamp traditional fermentation processes, and implement new technologies for enhanced automation. This transition necessitates a scalable and digital foundation that can increase throughput, model sample relationships, and offer easy access to crucial experimental data to optimize fermentation processes. Benchling's Industrial Biotechnology R&D Solution steps in as the trusted digital platform to meet these demands.

Read article

Revolutionizing Precision Medicine with Benchling: The AC Immune Case Study

Introduction to AC Immune and Benchling Collaboration

AC Immune, a clinical-stage biopharmaceutical company at the forefront of precision medicine for neurodegenerative diseases like Alzheimer's, Parkinson's, and NeuroOrphan indications, has joined forces with Benchling to revolutionize their data management and collaborative efforts. Leveraging two validated technology platforms, SupraAntigen® and Morphomer®, AC Immune aims to pioneer earlier diagnosis and prevention strategies for neurodegeneration.

Read article

Welcome to Knowledge Base!

KB at your finger tips

Products-Benchling